Start for free
Start for free
KH

Kurt Hilzinger

North America, Pennsylvania, United States, Haverford

Description

Kurt Hilzinger - Interim CEO @ The Harvard Drug Group

Investor Profile

Kurt Hilzinger has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Artificial Intelligence (Ai)
  • Biotechnology
  • Health Care
  • Hospital
  • Machine Learning
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Kurt Hilzinger frequently co-invest with?

Gaingels
Gaingels
North America, Vermont, United States, Burlington
Co-Investments: 1
M13
M13
North America, California, United States, Santa Monica
Co-Investments: 1
GreatPoint Ventures
GreatPoint Ventures
North America, Michigan, United States, New Haven
Co-Investments: 1

What are some of recent deals done by Kurt Hilzinger?

Carenostics

Berwyn, Pennsylvania, United States

Carenostics provides underdiagnosis, undertreatment, and health inequities of chronic disease treatment using AI & ML.

Artificial Intelligence (AI)BiotechnologyHealth CareHospitalMachine Learning
SeedSep 13, 2023
Amount Raised: $5,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator